BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33144282)

  • 1. Drug Use and Cancer Risk: A Drug-Wide Association Study (DWAS) in Norway.
    Støer NC; Botteri E; Thoresen GH; Karlstad Ø; Weiderpass E; Friis S; Pottegård A; Andreassen BK
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):682-689. PubMed ID: 33144282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Wide Association Study (DWAS): Challenges and Opportunities.
    Wang Y; Gadalla SM
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):597-599. PubMed ID: 33811172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.
    Berge LAM; Andreassen BK; Stenehjem JS; Larsen IK; Furu K; Juzeniene A; Roscher I; Heir T; Green A; Veierød MB; Robsahm TE
    BMJ Open; 2019 Feb; 9(2):e025246. PubMed ID: 30787091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.
    Andreassen BK; Støer NC; Martinsen JI; Ursin G; Weiderpass E; Thoresen GH; Debernard KB; Karlstad Ø; Pottegard A; Friis S
    BMJ Open; 2019 Apr; 9(4):e028504. PubMed ID: 30962244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study.
    Romanowska J; Bjornevik K; Cortese M; Tuominen JA; Solheim M; Abolpour Mofrad A; Igland J; Scherzer CR; Riise T
    Neurology; 2023 Nov; 101(21):e2068-e2077. PubMed ID: 37816645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.
    Engeland A; Bramness JG; Daltveit AK; Rønning M; Skurtveit S; Furu K
    Br J Clin Pharmacol; 2008 May; 65(5):653-60. PubMed ID: 18294334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
    Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.
    Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Karlstad Ø; Juzeniene A; Ghiasvand R; Larsen IK; Green AC; Veierød MB; Robsahm TE
    Clin Epidemiol; 2020; 12():1389-1401. PubMed ID: 33376408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
    Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
    Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advice on drug safety in pregnancy: are there differences between commonly used sources of information?
    Frost Widnes SK; Schjøtt J
    Drug Saf; 2008; 31(9):799-806. PubMed ID: 18707194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry.
    Benjaminsen E; Myhr KM; Grytten N; Alstadhaug KB
    Mult Scler Relat Disord; 2021 Feb; 48():102691. PubMed ID: 33360174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study.
    Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Furu K; Juzeniene A; Roscher I; Larsen IK; Green AC; Veierød MB; Robsahm TE
    Clin Epidemiol; 2020; 12():193-202. PubMed ID: 32110111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women.
    Kvåle G; Heuch I; Nilssen S
    Int J Epidemiol; 1994 Aug; 23(4):691-9. PubMed ID: 8002181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic assessment of prescribed medications and short-term risk of myocardial infarction - a pharmacopeia-wide association study from Norway and Sweden.
    Sen A; Vardaxis I; Lindqvist BH; Brumpton BM; Strand LB; Bakken IJ; Vatten LJ; Romundstad PR; Ljung R; Mukamal KJ; Janszky I
    Sci Rep; 2019 Jun; 9(1):8257. PubMed ID: 31164670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
    Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.